Cleveland Clinic breast cancer vaccine could conquer disease and defeat it for good

 So Tuohy and his colleagues created a vaccine that
A vaccine to prevent breast cancer being developedseeks alpha-lactalbumin, which is a protein found in
by Cleveland Clinic researchers has shownthe majority of breast cancers, but is not found in
"overwhelmingly favorable results" in animals andhealthy women except when they breast-feed. The
could be on its way to conquering the disease thatvaccine would destroy healthy breast tissue of
kills more than 40,000 American women each year.women who are lactating, so these women likely
Researchers led by Vincent Tuohy, an immunologistwould not get the vaccine.
at the Clinic's Lerner Research Institute, have foundBecause the protein is linked to lactation, the
that a single vaccination with the antigenstrategy behind the new vaccine would be to
alpha-lactalbumin prevents breast cancer tumors fromvaccinate women who are over 40 years old —
forming in mice and inhibits the growth of existingwhen the risk of breast cancer begins to rise and
tumors.pregnancy becomes less likely. Younger women at
Enrollment in human trials could begin next year. Ifheightened risk for breast cancer could consider the
successful, the vaccine would be the first to preventvaccine as an alternative to prophylactic mastectomy.
breast cancer and could point the way to vaccines"Most attempts at cancer vaccines have targeted
for other cancers. It also could be a huge commercialviruses or cancers that have already developed," said
success for the Clinic, which typically licenses or spinsDr. Joseph Crowe, director of the Clinic's Breast
off its discoveries to companies that take them toCenter, in the release. "Dr. Tuohy is not a breast
market.cancer researcher, he's an immunologist, so his
"We believe that this vaccine will someday be usedapproach is completely different — attacking the
to prevent breast cancer in adult women in the sametumor before it can develop. It's a simple concept,
way that vaccines have prevented many childhoodyet one that has not been explored until now."
diseases," said Tuohy, the study's principalA year ago, Tuohy, who studies autoimmune
investigator, in a press release. "If it works in humansdiseases such as multiple sclerosis, was surprised
the way it works in mice, this will be monumental.when the National Institutes of Health backed
We could eliminate breast cancer."development of his breast cancer vaccine after his
Tuohy's research will be published online today at andfirst request. Usually, it takes several requests to land
in the June 10 issue of the Nature Medicine journal.grants in the neighborhood of $1.3 million.
In Tuohy's study, cancer-prone mice were vaccinatedSeveral clinical trials are underway for breast cancer
— half with a vaccine containing alpha-lactalbuminvaccines. The University of Arkansas is working on a
and half with a vaccine that did not contain thetherapeutic vaccine that tricks the body into
antigen. Not one of the mice vaccinated withproducing cancer-fighting antigens, while Generex
alpha-lactalbumin developed breast cancer, while all ofBiotechnology has had successful early phase trials
the other mice did.with breast cancer patients on its therapeutic vaccine.
The Food and Drug Administration has approvedBut few if any researchers appear to be going for a
cancer-preventing vaccines for cervical and liverprophylactic vaccine — one that prevents cancer.
cancers — both act on viruses that cause theTuohy envisions an adult vaccination program like
cancers, not on cancer formation.those that vaccinate children against diseases like
In developing his vaccine, Tuohy solved the quandarypolio and measles.
of targeting cancer — an overdevelopment of the"When you are an adult, you could be vaccinated
body's own cells — rather than a foreignagainst adult diseases like breast cancer, ovarian
substance, such as a virus. Vaccinating against a viruscancer, prostate cancer and so forth. Maybe even
destroys the virus, but vaccinating against a person'sAlzheimer's," Tuohy said.
own cells destroys healthy cells.  <!--WISESTAMP_SIG_START--><!